AVMA-endorsed xylazine legislation reintroduced in CongressFebruary 20, 2025The AVMA reintroduced the Combating Illicit Xylazine Act in both the House and Senate. The legislation is reported to provide the U.S. Drug Enforcement Administration (DEA) with tools to help address the illicit drug by scheduling xylazine as a Schedule III drug, ensure common veterinary uses of the drug remain legal, help maintain the availability of the drug on the market for veterinarians, and allow the DEA to track the legitimate supply.
Education Center - SponsoredReclaiming Lost Hours: How Digital Prescription Management Is Reshaping Veterinary Workflowsby • MWI Animal HealthAs administrative burdens grow, digital prescription management offers veterinary teams a path to greater efficiency, fewer errors, and more time for patient care.
New report proposes solutions to advance role of pets for better mental healthFebruary 18, 2025The Human Animal Bond Research Institute (HABRI) issued a new report, The Role of Companion Animals for Improved Mental Health, earlier this month, that focuses on providing data, insights, and best practices to boost awareness and implementation of policies and programs that elevate the role of pets for improved mental health.
Zoetis receives conditional license from USDA for Avian Influenza VaccineFebruary 17, 2025 Zoetis announced on Friday the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is labelled for use in chickens. The conditional license was granted on the demonstration of safety, purity, and reasonable expectation of efficacy based on serology data.
Trupanion IDs which Valentine's Day gift has proven most hazardous to pets—and it's not chocolateFebruary 14, 2025Since 2019, Trupanion has had 1,740 claims for chocolate toxicity-related claims around Valentine’s Day. On average Trupanion paid $727 for chocolate-related claims, with the highest claim being $9,376.
VPN Plus+ ExclusiveThe fight between generalists vs. specialistsFebruary 12, 2025By Patty Khuly, VMD, MBA
VPN Plus+ ExclusiveOvercoming the neurologic disease severity-prognosis mismatch – Part twoFebruary 7, 2025
